The antiphospholipid syndrome may present itself to virtually all medical specialties. It can be as non-threatening as thrombophlebitis or mild thrombocytopenia or as severe as cerebral arterial infarct or the so called “catastrophic APS”. In order to diagnose it properly, it is important to be aware of its clinical manifestations and laboratory peculiarities. The primary form of APS seems to be more common than the SLE related one. Because any artery or vein may be involved, the spectrum of clinical manifestations of APS is so wide that they include virtually all medical specialties.
HughesGRV. Thrombosis abortion cerebral disease and lupus anticoagulant. Br Med J1983; 287: 1088–1089
2.
KamashtaMA. The Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. Br J Rheumatol1995; 34: 493–497
3.
HarrisENAnticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet1983; 2: 1211–1214
4.
AshersonRA. A ‘primary’ antiphospholipid syndrome?. J Rheumatol1988; 15: 1742–1746
DelezeMOccurrence of both hemolytic anemia and thrombocytopenic purpura (Evan's syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol1988; 15: 611–615
10.
ViannaJLComparison of the primary and secondary antiphospholipid syndrome: a European multicentre study of 114 patients. Am J Med1994; 96: 3–9
11.
HughesGRV. The antiphospholipid syndrome: ten years on. Lancet1993; 342: 341–344
12.
AshersonRAHughesGRV. The expanding spectrum of Libman-Sacks endocarditis: the role of antiphospholipid syndrome. Clin Exp Rheumatol1989; 7: 225–228
13.
HojnikMHeart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation1996; 93: 1579–1587
14.
AmesPRJClinical and therapeutic aspects of the antiphospholipid syndrome. Lupus1995; 4: S23–S25
15.
MortonKECoronary artery bypass failure: an autoimmune phenomenon?. Lancet1986; 2: 1353–1357
16.
VaaralaOCross-reaction between antibodies to oxidised low density lipoprotein and cardiolipin in systemic lupus erythematosus. Lancet1993; 341: 923–925
17.
WeinsteinCLivido reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol1987; 123: 590–600
18.
AshersonRAThe spectrum of livido reticularis and anticardiolipin antibodies. Br J Rheumatol1989; 120: 215–221
19.
StephensCJM. The antiphospholipid syndrome. Clinical correlations, cutaneous features, mechanism of thrombosis and treatment of patients with lupus anticoagulant and anticardiolipin antibodies. Br J Dermatol1991; 125: 199–210
20.
AshersonRAHughesGRV. Addison's disease in the primary antiphospholipid syndrome. Ann Rheum Dis1989; 16: 378–380
21.
AshersonRA. Hypoadrenalism and the antiphospholipid syndrome: an important cause of ‘idiopathic’ Addison's disease. Lupus1994; 3: 334 (abstract)
22.
Mackworth-YoungCGPortal and pulmonary hypertension in a case of systemic lupus erythematosus: possible relationship with clotting abnormality. Eur J Rheumatol Inflam1984; 7: 71–74
23.
PelletierSThe antiphospholipid syndrome as the second cause of non-malignant Budd-Chiari syndrome. Arthritis Rheum1992; 35 (suppl): s238
24.
AshersonRARecurrent stroke and multi-infarct dementia in SLE with antiphospholipid antibodies. Ann Rheum Dis1987; 46: 605–611
25.
HerranzMTAssociation between antiphospholipid antibodies and epilepsy in patients with SLE. Arthritis Rheum1994; 37: 568–571
26.
AshersonRAChorea in systemic lupus and lupus-like disease: association with antiphospholipid antibodies. Arthritis Rheum1987; 16: 253–259
27.
OstuniPARenal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann Rheum Dis1990; 49: 184–187
28.
AshersonRARenal artery stenosis and hypertension in primary antiphospholipid syndrome. J Rheumatol1991; 18: 1413–1415
29.
GlueckIThrombosis in systemic lupus erythematosus: relation to the presence of circulating anticoagulantArch Intern Med1985; 145: 1389–1395
30.
Kincaid-SmithPLupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Q J Med1988; 69: 795–815
31.
AmigoMCRenal involvement in primary antiphospholipid syndrome. J Rheumatol1992; 19: 1181–1185
32.
AlmeshariKPrimary antiphospholipid syndrome and self-limited renal vasculitis during pregnancy: Case report and review of the literature. Am J Kid Dis1994; 24: 505–508
33.
BranchDWObstetric complications associated with lupus anticoagulant. N Engl J Med1985; 313: 1322–1326
34.
LockshinMDAntibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. New Engl J Med1985; 313: 152–156
35.
ShoenfeldYFishmanP. Role of IL-3 in the antiphospholipid syndrome. Lupus1994; 3: 259–261
36.
AngeliniLHigh prevalence of antiphospholipid antibody in children with cerebral idiopathic ischemia. Pediatrics1994; 94: 500–503
37.
MoltaCChildhood-onset systemic lupus erythematosus: antiphospholipid antibody in 37 patients and their first degree relatives. Pediatrics1993; 92: 849–853
38.
GattornoMAntiphospholipid antibody in pediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndrome: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol1995; 34: 873–881
BrucatoAPulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J Rheumatol1994; 21: 942–944
41.
GetnerELieJT. Pulmonary capillaritis, alveolar hemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol1993; 20: 1224–1228
42.
AshersonRAAseptic necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol1993; 20: 284–288
